Horizon Pharma Talks to Depomed Holders About Adding CashCrayton Harrison
Horizon Pharma Plc is talking to Depomed Inc. shareholders about a revised takeover offer that would include as much as 25 percent in cash, though the total value of the proposal would be lower than its current all-stock bid.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Tesla Unveils ‘World’s Fastest Production Car’ and Electric Big Rig
- Goldman Sachs Sees Four 2018 Fed Rate Hikes as U.S. Growth Gains
- Norway Idea to Exit Oil Stocks Is ‘Shot Heard Around the World’
- Honda Recalls 800,000 Odyssey Minivans Linked to Injuries
- The Questionable Math Behind Manafort’s Extravagant Home Renovations